Alnylam Pharmaceuticals, Inc. (ALNY)
297.45
-3.06
(-1.02%)
USD |
NASDAQ |
May 22, 16:00
297.45
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap : 39.71B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aldeyra Therapeutics, Inc. | 93.50M |
| Ionis Pharmaceuticals, Inc. | 12.49B |
| Sarepta Therapeutics, Inc. | 1.774B |
| BridgeBio Pharma, Inc. | 13.54B |
| BioMarin Pharmaceutical, Inc. | 10.45B |
Market Cap Related Metrics
| PE Ratio | 70.68 |
| PS Ratio | 9.410 |
| Price to Book Value | 36.93 |
| Price to Free Cash Flow | 62.90 |
| Price | 297.45 |
| Earnings Yield | 1.41% |
| Operating PE Ratio | 53.63 |
| Normalized PE Ratio | 72.13 |